Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cara Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.73 | €4.62 | 530.491% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.42 | €35.43 | 39.376% |
| Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.50 | €3.25 | 116.840% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.60 | €248.57 | 16.919% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.46 | €4.63 | 33.616% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €15.10 | €30.00 | 98.675% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.46 | €26.01 | 33.640% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.60 | €28.29 | 19.876% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.15 | €8.75 | 7.362% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €125.65 | €140.60 | 11.901% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €85.25 | €100.00 | 17.302% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €24.80 | - | - |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.56 | €4.00 | 56.250% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €287.95 | €297.31 | 3.251% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.40 | €421.61 | 16.017% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.21 | €19.86 | 220.143% |
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.73 | - | - |
| Icon plc | 18 | 0 | 3 | 0 | €287.00 | €319.67 | 11.383% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.00 | - | - |